Trial watch: PCSK9 antibody reduces LDL cholesterol.
Sarah
S
Crunkhorn
D000818:Animals; D000911:Antibodies, Monoclonal / Q000502:physiology*; D008078:Cholesterol, LDL / Q000037:antagonists & inhibitors* / Q000097:blood; D002986:Clinical Trials as Topic / Q000639:trends; D017322:Clinical Trials, Phase II as Topic / Q000639:trends*; D016503:Drug Delivery Systems / Q000379:methods; D006801:Humans; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases / Q000276:immunology*; D012697:Serine Endopeptidases / Q000276:immunology*; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology*
D000911:Antibodies, Monoclonal; D008078:Cholesterol, LDL; D015842:Serine Proteinase Inhibitors; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D012697:Serine Endopeptidases